Find clinical trials for Heart Disease in Taipei City
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Heart Disease trials near Taipei City, TWN:
with placebo in reducing the risk of the clinical consequences of AKI (MAKE) at 90 days in adult participants with CKD who undergo non-emergent cardiac...
Phase 3
Taipei City, Taiwan and 206 other locations
the safety and efficacy of drug-coated balloon (DCB) treatment compared to drug-eluting stenting (DES) in patients with large coronary artery disease...
New Taipei City, Taiwan and 18 other locations
whether a medicine called BI 690517 helps people with chronic kidney disease when taken in combination with a study medicine called empaglif ...
Phase 3
Taipei, Taiwan and 47 other locations
The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with...
Taipei, Taiwan and 66 other locations
This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...
Phase 3
Taipei, Taiwan and 851 other locations
The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease...
Phase 3
Taipei, Taiwan and 736 other locations
cardiovascular events (MACE) including coronary heart disease (CHD) death, ischemic stroke, myocardial infarction (MI), acute limb...
Phase 3
Taipei, Taiwan and 655 other locations
and pharmacodynamics of 4D-310 following a single IV administration. The study population is comprised of adult males and females with Fabry Disease...
Phase 1, Phase 2
Taipei, Taiwan and 3 other locations
for isolated CABG for multi-vessel coronary artery disease and deemed technically suitable for sternotomy CABG as well as for MICS CABG are...
Taipei, Taiwan and 12 other locations
administering low dose rivaroxaban to reduce the risk of major adverse cardiac event (MACE) in people with Chronic Kidney Disease ...
Phase 3
Taipei, Taiwan and 82 other locations
Clinical trials
Research sites
Resources
Legal